US Stock MarketDetailed Quotes
GRCE Grace Therapeutics
- 3.388
- +0.108+3.30%
Trading Nov 25 10:53 ET
34.35MMarket Cap-3723P/E (TTM)
3.445High3.283Low14.39KVolume3.283Open3.280Pre Close48.58KTurnover0.31%Turnover RatioLossP/E (Static)10.14MShares3.60052wk High0.61P/B15.74MFloat Cap1.98052wk Low--Dividend TTM4.65MShs Float2016.000Historical High--Div YieldTTM4.94%Amplitude1.720Historical Low3.375Avg Price1Lot Size
Grace Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | -43.83%15.17M | -10.34%19.41M | -17.52%23.01M | -17.52%23.01M | -19.65%25.11M | -22.71%27.01M | -43.61%21.65M | -36.12%27.89M | -36.12%27.89M | -32.53%31.26M |
| -Cash and cash equivalents | -43.85%15.16M | -10.35%19.39M | -17.47%23.01M | -17.47%23.01M | -29.33%18.55M | -22.72%26.99M | -43.63%21.63M | -8.12%27.88M | -8.12%27.88M | -20.51%26.24M |
| -Short-term investments | 0.00%15K | 0.00%15K | --0 | --0 | 30.99%6.57M | 7.14%15K | -6.25%15K | -99.89%15K | -99.89%15K | -62.33%5.02M |
| Receivables | -50.42%415K | -52.45%398K | -9.98%722K | -9.98%722K | 23.26%959K | -2.56%837K | -13.17%837K | 46.35%802K | 46.35%802K | 226.89%778K |
| -Accounts receivable | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 226.89%778K |
| -Accrued interest receivable | --0 | -90.00%5K | -71.15%15K | -71.15%15K | --164K | --94K | --50K | 372.73%52K | 372.73%52K | ---- |
| -Taxes receivable | 9.72%395K | -12.44%373K | -6.51%316K | -6.51%316K | --411K | --360K | --426K | 83.70%338K | 83.70%338K | ---- |
| -Other receivables | -94.78%20K | -94.46%20K | -5.10%391K | -5.10%391K | --384K | --383K | --361K | 16.71%412K | 16.71%412K | ---- |
| Prepaid assets | -54.31%477K | -44.81%622K | -52.68%283K | -52.68%283K | -22.17%811K | -22.90%1.04M | -26.77%1.13M | -16.94%598K | -16.94%598K | -43.58%1.04M |
| Total current assets | -44.40%16.06M | -13.48%20.43M | -18.03%24.01M | -18.03%24.01M | -19.58%26.88M | -22.98%28.89M | -42.76%23.61M | -35.32%29.29M | -35.32%29.29M | -31.78%33.43M |
| Non current assets | ||||||||||
| Net PPE | -63.16%21K | -85.16%23K | -95.77%24K | -95.77%24K | -94.16%35K | -90.98%57K | -82.95%155K | 0.35%567K | 0.35%567K | 2,622.73%599K |
| -Gross PPE | -63.16%21K | -85.16%23K | -38.61%722K | -38.61%722K | -94.16%35K | -90.98%57K | -82.95%155K | 16.32%1.18M | 16.32%1.18M | 2,622.73%599K |
| -Accumulated depreciation | ---- | ---- | -14.61%-698K | -14.61%-698K | ---- | ---- | ---- | -36.55%-609K | -36.55%-609K | ---- |
| Goodwill and other intangible assets | 0.00%49.27M | 0.00%49.27M | 0.00%49.27M | 0.00%49.27M | -40.48%49.27M | -40.48%49.27M | -40.48%49.27M | -40.48%49.27M | -40.48%49.27M | 26.94%82.77M |
| -Goodwill | 0.00%8.14M | 0.00%8.14M | 0.00%8.14M | 0.00%8.14M | -37.23%8.14M | -37.23%8.14M | -37.23%8.14M | -37.23%8.14M | -37.23%8.14M | --12.96M |
| -Other intangible assets | 0.00%41.13M | 0.00%41.13M | 0.00%41.13M | 0.00%41.13M | -41.09%41.13M | -41.09%41.13M | -41.09%41.13M | -41.09%41.13M | -41.09%41.13M | 7.06%69.81M |
| Total non current assets | -0.07%49.29M | -0.27%49.29M | -1.09%49.29M | -1.09%49.29M | -40.87%49.3M | -40.86%49.32M | -40.94%49.42M | -40.20%49.83M | -40.20%49.83M | 27.81%83.37M |
| Total assets | -16.44%65.35M | -4.54%69.72M | -7.36%73.3M | -7.36%73.3M | -34.77%76.19M | -35.32%78.21M | -41.54%73.03M | -38.48%79.12M | -38.48%79.12M | 2.25%116.8M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Payables | 129.85%2.05M | 100.22%1.79M | -36.90%1.51M | -36.90%1.51M | -63.87%1.21M | -76.14%891K | -70.87%892K | -16.43%2.39M | -16.43%2.39M | 18.19%3.36M |
| -accounts payable | 144.53%1.68M | 155.19%1.55M | -18.92%1.01M | -18.92%1.01M | -72.83%913K | -81.66%685K | -80.18%607K | -25.98%1.24M | -25.98%1.24M | 18.19%3.36M |
| -Other payable | 81.07%373K | -16.84%237K | -56.36%501K | -56.36%501K | --301K | --206K | --285K | -2.88%1.15M | -2.88%1.15M | ---- |
| Current accrued expenses | 36.09%626K | -18.11%814K | -81.40%176K | -81.40%176K | --532K | --460K | --994K | 219.59%946K | 219.59%946K | ---- |
| Current debt and capital lease obligation | ---- | ---- | ---- | ---- | -67.12%24K | -34.29%46K | -87.60%80K | -27.88%75K | -27.88%75K | 231.82%73K |
| -Current capital lease obligation | ---- | ---- | --0 | --0 | -67.12%24K | -34.29%46K | -87.60%80K | -27.88%75K | -27.88%75K | 231.82%73K |
| Current liabilities | 91.41%2.67M | 32.25%2.6M | -50.63%1.68M | -50.63%1.68M | -48.44%1.77M | -63.29%1.4M | -46.97%1.97M | 4.63%3.41M | 4.63%3.41M | 18.50%3.43M |
| Non current liabilities | ||||||||||
| Long term debt and capital lease obligation | ---- | ---- | --0 | --0 | --0 | --0 | --0 | 114.66%410K | 114.66%410K | --430K |
| -Long term capital lease obligation | ---- | ---- | --0 | --0 | --0 | --0 | --0 | 114.66%410K | 114.66%410K | --430K |
| Non current deferred liabilities | -40.43%3.94M | -32.12%4.79M | -24.95%5.51M | -24.95%5.51M | -60.52%6.4M | -59.91%6.61M | -57.61%7.06M | -56.50%7.35M | -56.50%7.35M | --16.22M |
| Derivative product liabilities | -24.70%2.6M | --2.96M | --4.36M | --4.36M | --3.33M | --3.46M | ---- | --0 | --0 | --0 |
| Total non current liabilities | -35.03%6.54M | 9.88%7.75M | 27.28%9.87M | 27.28%9.87M | -41.52%9.74M | -40.57%10.07M | -58.05%7.06M | -54.61%7.76M | -54.61%7.76M | 6,111.94%16.65M |
| Total liabilities | -19.62%9.22M | 14.75%10.35M | 3.48%11.56M | 3.48%11.56M | -42.71%11.51M | -44.74%11.47M | -56.05%9.02M | -45.12%11.17M | -45.12%11.17M | 534.47%20.08M |
| Shareholders'equity | ||||||||||
| Share capital | 0.00%261.04M | 1.06%261.04M | 1.06%261.04M | 1.06%261.04M | 1.06%261.04M | 1.06%261.04M | 0.04%258.29M | 0.12%258.29M | 0.12%258.29M | 0.12%258.29M |
| -common stock | 0.00%261.04M | 1.06%261.04M | 1.06%261.04M | 1.06%261.04M | 1.06%261.04M | 1.06%261.04M | 0.04%258.29M | 0.12%258.29M | 0.12%258.29M | 0.12%258.29M |
| Retained earnings | -5.65%-217.17M | -5.66%-213.74M | -6.48%-211.12M | -6.48%-211.12M | -22.92%-207.95M | -24.36%-205.56M | -26.15%-202.29M | -27.23%-198.27M | -27.23%-198.27M | -11.35%-169.18M |
| Paid-in capital | 5.75%18.3M | 28.89%18.1M | 27.91%17.86M | 27.91%17.86M | 29.25%17.63M | 31.11%17.31M | 11.29%14.04M | 14.90%13.97M | 14.90%13.97M | 18.24%13.64M |
| Gains losses not affecting retained earnings | 0.00%-6.04M | 0.00%-6.04M | 0.00%-6.04M | 0.00%-6.04M | 0.00%-6.04M | 0.03%-6.04M | 0.02%-6.04M | -0.02%-6.04M | -0.02%-6.04M | 7.58%-6.04M |
| Total stockholders'equity | -15.90%56.13M | -7.26%59.36M | -9.14%61.74M | -9.14%61.74M | -33.13%64.68M | -33.36%66.75M | -38.69%64.01M | -37.24%67.96M | -37.24%67.96M | -12.91%96.72M |
| Total equity | -15.90%56.13M | -7.26%59.36M | -9.14%61.74M | -9.14%61.74M | -33.13%64.68M | -33.36%66.75M | -38.69%64.01M | -37.24%67.96M | -37.24%67.96M | -12.91%96.72M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data